Prosecution Insights
Last updated: May 29, 2026

Tempus AI Inc.

17 pending office actions • 10 art units • 15 examiners • 0 of 17 (0%) have an AI response strategy ready • 13 patents granted in the last 365 days

Portfolio Summary

17
Total Pending OAs
9
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

9
Overdue
2
Due this week
6
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (9)Due ≤ 7 days (2)Due ≤ 30 days (6)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (29%)
12
Medium (71%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only5 (29%)
§103 only11 (65%)
§102 only1 (6%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
47% of docket
2
Information Tech
12% of docket
1
Communications
6% of docket
0
Semiconductors
0% of docket
6
Mechanical / Eng
35% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

170 h
Manual time on pending OAs
34 h
Time saved (low, 20%)
59 h
Time saved (mid, 35%)
1.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
MINCHELLA, KAITLYN L 3 27.1% +21.7%
SABOUR, GHAZAL 1 28.1% +28.6%
MOSER, BRUCE M 1 84.3% +20.1%
LIU, GUOZHEN 1 49.0% +24.7%
BORISSOV, IGOR N 1 27.7% +41.5%
PERUNGAVOOR, SATHYANARAYA V 1 64.6% +37.7%
ILAGAN, VINCENT CAESAR 1 41.7% +63.6%
VARNDELL, ROSS E 1 84.5% +13.2%
MERCHANT, SHAHID R 1 28.7% +25.2%
COVINGTON, AMANDA R 1 21.8% +30.0%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19067139 ARTIFICIAL INTELLIGENCE ENGINE FOR DIRECTED HYPOTHESIS GENERATION AND RANKING MOSER, BRUCE M 19d overdue
18433240 DETERMINING BIOMARKERS FROM HISTOPATHOLOGY SLIDE IMAGES VARNDELL, ROSS E 5d

Hard Cases (10)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17735117 METHOD AND PROCESS FOR PREDICTING AND ANALYZING PATIENT COHORT RESPONSE, PROGRESSION, AND SURVIVAL MINCHELLA, KAITLYN L 145d overdue
18398649 SYSTEMS AND METHODS FOR PREDICTING PATIENT RECRUITMENT AT CLINICAL SITES MERCHANT, SHAHID R 111d overdue
19210931 CANCER TREATMENT EFFICACY EVALUATION UPON UNDERGOING OR COMPLETING A CANCER TREATMENT SABOUR, GHAZAL 58d overdue
16888357 PAN-CANCER MODEL TO PREDICT THE PD-L1 STATUS OF A CANCER CELL SAMPLE USING RNA EXPRESSION DATA AND OTHER PATIENT DATA MINCHELLA, KAITLYN L 46d overdue
18930786 ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCING LIU, GUOZHEN 25d overdue
18544092 SYSTEMS, METHODS, AND ARTICLES FOR STRUCTURED ELECTRONIC HEALTH RECORD IMPUTATION USING DIAGNOSTIC TEMPORAL WINDOW COVINGTON, AMANDA R 7d
18679353 Systems and Methods for Selecting a Task-Specific Machine-Learning Model for Addressing a Clinical Task BORISSOV, IGOR N 12d
16889779 SYSTEMS AND METHODS OF CLINICAL TRIAL EVALUATION COBANOGLU, DILEK B 16d

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17735117 METHOD AND PROCESS FOR PREDICTING AND ANALYZING PATIENT COHORT RESPONSE, PROGRESSION, AND SURVIVAL MINCHELLA, KAITLYN L 145d overdue
18398649 SYSTEMS AND METHODS FOR PREDICTING PATIENT RECRUITMENT AT CLINICAL SITES MERCHANT, SHAHID R 111d overdue
18635663 SYSTEMS AND METHODS FOR PREDICTING CLINICAL RESPONSE ILAGAN, VINCENT CAESAR 99d overdue
19210931 CANCER TREATMENT EFFICACY EVALUATION UPON UNDERGOING OR COMPLETING A CANCER TREATMENT SABOUR, GHAZAL 58d overdue
16888357 PAN-CANCER MODEL TO PREDICT THE PD-L1 STATUS OF A CANCER CELL SAMPLE USING RNA EXPRESSION DATA AND OTHER PATIENT DATA MINCHELLA, KAITLYN L 46d overdue
18930786 ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCING LIU, GUOZHEN 25d overdue
19067139 ARTIFICIAL INTELLIGENCE ENGINE FOR DIRECTED HYPOTHESIS GENERATION AND RANKING MOSER, BRUCE M 19d overdue
18433240 DETERMINING BIOMARKERS FROM HISTOPATHOLOGY SLIDE IMAGES VARNDELL, ROSS E 5d

Top Art Units

Art UnitApps
1685 4
1686 3
3685 2
3686 2
2154 1
2488 1
2674 1
3684 1
1798 1
3687 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19210931 CANCER TREATMENT EFFICACY EVALUATION UPON UNDERGOING OR COMPLETING A CANCER TREATMENT SABOUR, GHAZAL 1686 §103 Non-Final OA 58d overdue Pending May 16, 2025
19067139 ARTIFICIAL INTELLIGENCE ENGINE FOR DIRECTED HYPOTHESIS GENERATION AND RANKING MOSER, BRUCE M 2154 §103 Non-Final OA 19d overdue Pending Feb 28, 2025
18930786 ESTIMATION OF CIRCULATING TUMOR FRACTION USING OFF-TARGET READS OF TARGETED-PANEL SEQUENCING LIU, GUOZHEN 1686 §101 Non-Final OA 25d overdue Pending Oct 29, 2024
18679353 Systems and Methods for Selecting a Task-Specific Machine-Learning Model for Addressing a Clinical Task BORISSOV, IGOR N 3685 §103 Final Rejection 12d Pending May 30, 2024
18651561 ATTENTION-BASED METHODS AND SYSTEMS FOR IMPROVING QUALITY CONTROL OF WHOLE-SLIDE IMAGE PREDICTIONS PERUNGAVOOR, SATHYANARAYA V 2488 §103 Non-Final OA 8d Pending Apr 30, 2024
18635663 SYSTEMS AND METHODS FOR PREDICTING CLINICAL RESPONSE ILAGAN, VINCENT CAESAR 3686 §103 Non-Final OA 99d overdue Pending Apr 15, 2024
18433240 DETERMINING BIOMARKERS FROM HISTOPATHOLOGY SLIDE IMAGES VARNDELL, ROSS E 2674 §103 Non-Final OA 5d Pending Feb 05, 2024
18398649 SYSTEMS AND METHODS FOR PREDICTING PATIENT RECRUITMENT AT CLINICAL SITES MERCHANT, SHAHID R 3684 §101 Final Rejection 111d overdue Pending Dec 28, 2023
18544092 SYSTEMS, METHODS, AND ARTICLES FOR STRUCTURED ELECTRONIC HEALTH RECORD IMPUTATION USING DIAGNOSTIC TEMPORAL WINDOW COVINGTON, AMANDA R 3686 §101 Final Rejection 7d Pending Dec 18, 2023
18091320 MULTIMODAL CARDIO DISEASE STATE PREDICTIONS COMBINING ELECTROCARDIOGRAM, ECHOCARDIOGRAM, CLINICAL AND DEMOGRAPHICAL INFORMATION RELATING TO A PATIENT SHELDEN, BION A 3685 §103 Non-Final OA 22d Pending Dec 29, 2022
17735117 METHOD AND PROCESS FOR PREDICTING AND ANALYZING PATIENT COHORT RESPONSE, PROGRESSION, AND SURVIVAL MINCHELLA, KAITLYN L 1685 §102 Final Rejection 145d overdue Pending May 03, 2022
17548084 Systems and Methods for Homogenization of Disparate Datasets HAYES, JONATHAN EDWARD 1685 §103 Non-Final OA 5d overdue Pending Dec 10, 2021
17400117 SYSTEMS AND METHODS FOR FLOW CELL SAMPLE ALLOCATION WHATLEY, BENJAMIN R 1798 §103 Final Rejection 70d overdue Pending Aug 12, 2021
17247510 Real-World Evidence of Diagnostic Testing and Treatment Patterns in U.S. Breast Cancer Patients with Implications for Treatment Biomarkers from RNA-Sequencing Data ZEMAN, MARY K 1686 §101 Non-Final OA 23d Pending Dec 14, 2020
16889779 SYSTEMS AND METHODS OF CLINICAL TRIAL EVALUATION COBANOGLU, DILEK B 3687 §101 Final Rejection 16d Pending Jun 01, 2020
16888357 PAN-CANCER MODEL TO PREDICT THE PD-L1 STATUS OF A CANCER CELL SAMPLE USING RNA EXPRESSION DATA AND OTHER PATIENT DATA MINCHELLA, KAITLYN L 1685 §103 Final Rejection 46d overdue Pending May 29, 2020
16732229 TRANSCRIPTOME DECONVOLUTION OF METASTATIC TISSUE SAMPLES MINCHELLA, KAITLYN L 1685 §103 Final Rejection 28d Pending Dec 31, 2019

Managing Tempus AI Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month